Log in to save to my catalogue

Tumor lysis syndrome in a chronic lymphocytic leukemia patient with pleural effusion after oral flud...

Tumor lysis syndrome in a chronic lymphocytic leukemia patient with pleural effusion after oral flud...

https://devfeature-collection.sl.nsw.gov.au/record/TN_cdi_proquest_miscellaneous_1540226487

Tumor lysis syndrome in a chronic lymphocytic leukemia patient with pleural effusion after oral fludarabine and cyclophosphamide therapy

About this item

Full title

Tumor lysis syndrome in a chronic lymphocytic leukemia patient with pleural effusion after oral fludarabine and cyclophosphamide therapy

Publisher

Tokyo: Springer Japan

Journal title

International journal of hematology, 2014-06, Vol.99 (6), p.782-785

Language

English

Formats

Publication information

Publisher

Tokyo: Springer Japan

More information

Scope and Contents

Contents

Tumor lysis syndrome (TLS) is a rare complication of the treatment for chronic lymphocytic leukemia (CLL). Since the advent of new therapeutic agents with higher response rates, however, TLS has been observed with increasing frequency. An 84-year-old woman with a nine-year history of untreated CLL presented with exacerbating dyspnea due to pleural...

Alternative Titles

Full title

Tumor lysis syndrome in a chronic lymphocytic leukemia patient with pleural effusion after oral fludarabine and cyclophosphamide therapy

Identifiers

Primary Identifiers

Record Identifier

TN_cdi_proquest_miscellaneous_1540226487

Permalink

https://devfeature-collection.sl.nsw.gov.au/record/TN_cdi_proquest_miscellaneous_1540226487

Other Identifiers

ISSN

0925-5710,1865-3774

E-ISSN

1865-3774

DOI

10.1007/s12185-014-1560-8

How to access this item